Page last updated: 2024-08-23

bisantrene and Adenocarcinoma

bisantrene has been researched along with Adenocarcinoma in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (90.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aisner, J; Fuks, JZ; Garbino, C; Kasdorf, H; Van Echo, DA	1
Forastiere, AA; Hughes, AK; Perry, MC; Wood, WC	1
Hahn, RG; Jones, AR; Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J	1
Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE	1
Faye, L; Scher, H; Schwartz, S; Watson, R; Yagoda, A	1
Coltman, CA; Kuhn, JG; Myers, JW; Pocelinko, R; Rivkin, S; Van Echo, D; Von Hoff, DD	1
Coltman, CA; Cowan, JD; Gumbart, C; Hutchins, LF; Martino, S; McClure, S; Neidhart, J; Osborne, CK; Stephens, RL; Vaughan, CB	1
Cullinan, SA; Kvols, LK; Laurie, JA; Mailliard, JA; Marschke, RF; O'Connell, MJ; Tschetter, LK	1
Andes, WA; Eyre, HJ; Grozea, PN; Jones, SE; O'Bryan, RM; Oishi, N; Panettiere, FJ; Taylor, SA	1
Blackstein, ME; Evans, WK; Osoba, D; Shepherd, FA; Taylor, D	1

Trials

2 trial(s) available for bisantrene and Adenocarcinoma

Article	Year
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay. Cancer research, 1982, Volume: 42, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms	1982
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study. Journal of the National Cancer Institute, 1991, Aug-07, Volume: 83, Issue:15 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Female; Humans; Middle Aged; Mitoxantrone	1991

Article

Year

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.

Cancer research, 1982, Volume: 42, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms

1982

Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.

Journal of the National Cancer Institute, 1991, Aug-07, Volume: 83, Issue:15

Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Female; Humans; Middle Aged; Mitoxantrone

1991

Other Studies

8 other study(ies) available for bisantrene and Adenocarcinoma

Article	Year
Treatment of advanced non-small cell lung cancer with bisantrene. Cancer treatment reports, 1983, Volume: 67, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged	1983
Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer. A cancer and leukemia group B study. Cancer chemotherapy and pharmacology, 1984, Volume: 13, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Hematopoietic Stem Cells; Humans; Middle Aged; Neoplasm Metastasis	1984
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma. American journal of clinical oncology, 1983, Volume: 6, Issue:4 Topics: Adenocarcinoma; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms	1983
Phase II trial of bisantrene for advanced hypernephroma. Cancer treatment reports, 1982, Volume: 66, Issue:8 Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Drug Evaluation; Humans; Kidney Neoplasms	1982
Phase II evaluation of bisantrene in patients with renal cell carcinoma. Cancer treatment reports, 1982, Volume: 66, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Bone Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged	1982
Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma. Medical and pediatric oncology, 1988, Volume: 16, Issue:4 Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Drug Evaluation; Infusion Pumps; Pancreatic Neoplasms; Remission Induction; Time Factors	1988
Bisantrene hydrochloride in gastric adenocarcinoma: a Southwest Oncology Group Study. Medical and pediatric oncology, 1986, Volume: 14, Issue:2 Topics: Adenocarcinoma; Anthracenes; Antibiotics, Antineoplastic; Humans; Stomach Neoplasms	1986
Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma. Cancer treatment reports, 1985, Volume: 69, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Phlebitis	1985